Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Sugi Pharmacy Installs Clean Benches in Drugstores
June 24, 2002
- BUSINESS NEWS IN BRIEF
June 24, 2002
- Terumo: Glucose Meter with Voice Guide Function
June 24, 2002
- Kusuri Provervs Reveal Japanese Spirit (11)
June 24, 2002
- J&J Sponsors Seminar on Shunt Intervention
June 24, 2002
- 29 Products Including Zomig RM Added to NHI List
June 24, 2002
- Medtronic, Baxter Present Reports on Products Using Swine Heart Valves
June 24, 2002
- Establishment of Fast-track System Requested Again by FPMAJ: PAL Hearings
June 24, 2002
- MEDICAL DEVICE NEWS IN BRIEF
June 24, 2002
- Iressa Recommended for Approval by CDFS Panel
June 24, 2002
- BD: New M. tuberculosis Susceptibility Testing Reagent
June 24, 2002
- Science and Technology White Paper Stresses Importance of Innovation
June 24, 2002
- MBL Gets License from Oncotherapy Science
June 24, 2002
- Precautions against Stevens-Johnson Syndrome Issued Again
June 24, 2002
- DIAGNOSTIC NEWS IN BRIEF
June 24, 2002
- GSK Publishes Review of Its Commitment to Society, Environment
June 17, 2002
- BUSINESS NEWS IN BRIEF
June 17, 2002
- OTC NEW IN BRIEF
June 17, 2002
- Taxotere-based Chemotherapy Improves Breast Cancer Survival
June 17, 2002
- Lilly's Drotrecogin Prolongs Survival of Severe Sepsis Patients
June 17, 2002
ページ
Japan’s pharmaceutical industry is undergoing a structural shift in its workforce, with the role of sales reps shrinking while production…
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…